1-32274765-G-A
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_005356.5(LCK):c.134G>A(p.Arg45Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00436 in 1,607,346 control chromosomes in the GnomAD database, including 456 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_005356.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LCK | NM_005356.5 | c.134G>A | p.Arg45Gln | missense_variant | 3/13 | ENST00000336890.10 | NP_005347.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LCK | ENST00000336890.10 | c.134G>A | p.Arg45Gln | missense_variant | 3/13 | 1 | NM_005356.5 | ENSP00000337825 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0111 AC: 1683AN: 152024Hom.: 115 Cov.: 32
GnomAD3 exomes AF: 0.0155 AC: 3821AN: 246356Hom.: 238 AF XY: 0.0119 AC XY: 1576AN XY: 132926
GnomAD4 exome AF: 0.00365 AC: 5313AN: 1455204Hom.: 338 Cov.: 32 AF XY: 0.00315 AC XY: 2281AN XY: 723146
GnomAD4 genome AF: 0.0112 AC: 1699AN: 152142Hom.: 118 Cov.: 32 AF XY: 0.0126 AC XY: 938AN XY: 74390
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Severe combined immunodeficiency due to LCK deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Nov 12, 2023 | This variant is classified as Benign based on local population frequency. This variant was detected in 22% of patients studied by a panel of primary immunodeficiencies. Number of patients: 21. Only high quality variants are reported. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at